tb-500 + bpc-157 575 mg dosagem (5/5 MG) BPC157 & TB500 Blend (10mg/10mg)
Description
BPC-157 prevented catalepsy development when given before reserpine and reversed established catalepsy when administered 24 hours after vesicle depletion
Single-use vials force wasteful re-opening of new solvent bottles each time
Are BPC-157 and BPC-159 intended for human consumption
Use in conjunction with diet, sleep, and stress care for optimal results
These benefits appear to be related, in part, to enhanced recruitment of collateral circulation, which supports oxygen delivery to compromised cardiac tissue
